Skip to main content
Clinical Trials/NL-OMON22012
NL-OMON22012CompletedNot Applicable

A randomized, multicentre, open label trial comparing the start of the induction of labor with intravenous oxytocin according to the circadian rhythm with standard care.

AMC:J.J.H. Bakker, Dr.J.A.M. van der Post, Dr.R. de Vos.OLVG: Dr.J.M.M.van LithSLVZ:Drs.A.J.van Veelen0 sites400 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
400

Study Overview

Brief Summary

/A

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Women are eligible to participate when the clinician judges that it is indicated to induce labor and the cervix is favourable for induction with a drip of oxytocin.

Exclusion Criteria

  • Excluded are women with:
  • 1. Intrauterine fetal death;

Investigators

Sponsor
AMC:J.J.H. Bakker, Dr.J.A.M. van der Post, Dr.R. de Vos.OLVG: Dr.J.M.M.van LithSLVZ:Drs.A.J.van Veelen

Similar Trials

Active, not recruiting
Not Applicable
A randomized, multicenter open label study comparing cyclosporine with infliximab in steroid-refractory severe attacks of ulcerative colitis (CYSIF Study) - CYSIF
EUCTR2006-005299-42-BEGETAID100
Active, not recruiting
Not Applicable
A randomized, multicenter open label study comparing cyclosporine with infliximab in steroid-refractory severe attacks of ulcerative colitis (CYSIF Study) - CYSIF- Diagnosis of UC according to Lennard-Jones criteria - Endoscopically demonstrated colorectal lesions localized above the anal margin and extending at least up to 15cm proximally.- Severe acute flare of UC with a Lichtiger Index score > 10.- Refractoriness to high dose intravenous steroid therapy (= 0.8 mg/kg/d of methylprednisolone or equivalent) given for at least 5 days.MedDRA version: 9.1Level: LLTClassification code 10045282Term: UC
EUCTR2006-005299-42-FRGETAID100
Active, not recruiting
Not Applicable
A randomized, multicentre, open label study comparing cyclosporine with infliximab in steroid-refractory severe attacks of ulcerative colitisSatunnaistettu, avoin, vertaileva monikeskustutkimus siklosporiinista ja infliximabista kortikosteroidille reagoimattoman vaikean haavaisen paksusuolitulehduksen hoidossa. - CYSIF STUDY
EUCTR2006-005299-42-FIGroupe d'Etude Thérapeutique des Affections Inflammatoires Digestives (G.E.T.A.I.D.)100
Suspended
Not Applicable
A comparison of once daily insulin detemir given pre-breakfast or bedtime, according to need, with bedtime insulin glargine in people with type 2 diabetes characterized by an asymmetric insulin requirement across the day and night.Type 2 diabetes.
NL-OMON25809Dr. J.H. de VriesAcademic Medical Center - AmsterdamandProf. Philip HomeUniversity of Newcastle upon Tyne, UK175
Completed
Phase 4
A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus IFX to Steroids Plus Azathioprine for Acute Severe ColitisUlcerative Colitis
NCT02425852Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives65